JAS IN ASIA PACIFIC

News From JAS Worldwide - Asia Pacific Focus

JAS APAC HQ

111 Somerset Road, #06-20

​TripleOne Somerset

Singapore

JAS Korea, a Specialized Solution in the Pharma Industry

By
Yousuk Kim
June 23, 2020

As economies around the world are suffering from the impact of Covid-19, businesses are experiencing losses, workers are without jobs, and many face the challenge of a complete upheaval of lifestyle. However, pharmaceutical companies are taking center stage in the Covid-19 fight, and one of these is a Korean conglomerate, SK Group, is seeing growth on the stock market and a new burst of innovation in the infectious disease landscape as the race for treatment approval for a Covid-19 therapy takes off.

SK Group, the 2nd largest group in Korea after Samsung with an annual revenue of $213.6B in 2018, has two arms of pharmaceutical subsidiaries, SK Pharmteco, the pharmaceutical intermediate, and API manufacturer & SK Biopharmaceuticals, the new drug development.

With support from JAS APAC & JAS Worldwide, JAS Korea has become a contracted freight forwarding business partner for SK Biotek as of last December, then after months of implementation period, JAS has been handling various types of Pharmaceutical export shipments by Air & Ocean to additional International Pharmaceutical companies in Europe.

Due to the nature of the cargo, pharmaceutical products, they must be mostly carried by air freight, using special equipment such as dry ice gel/ ice pack, cool/ reefer truck, temperature-controlled storage, and even RKNs which require thorough knowledge and experience to handle such a commodity properly and in a timely manner.

The RKN e1 is a one pallet size container, based on a second-generation active temperature control system and utilizes compressor cooling and electric heating technology, to meet the requirements of the pharmaceutical industry for smaller air shipments.

The RKN e1 container maintains product temperatures in the +2 to +8 °C range, controlled room temperature (+15 to +25 °C) range,  JAS Korea has successfully arranged 11 RKN e1 for its door to door delivery to a Spanish Pharmaceutical consignee with Dap term in March, when the Pandemic was in the peak.

SK Pharmteco’s subsidiary, AMPAC is one of the strategic partners to a U.S. public benefit drug manufacturing corporation, which recently received federal government funding of $354 million for advanced manufacturing of America’s most essential medicines at risk of shortage, including those for the COVID-19 response. With its strategic partners, it has initiated manufacturing chemical precursor ingredients, active pharmaceutical ingredients (APIs), and finished dosage forms for over a dozen essential medicines to treat hospitalized patients with COVID-19-related illnesses.

SK Biotek will supply pharmaceutical intermediates to AMPAC and has appointed JAS Korea as the logistics provider for this project. The 1st air shipment was exported to AMPAC in California, USA by suing 5 x RKN e 1 in close cooperation with JAS San Francisco on June 15th, all 5 x RKNs were successfully delivered to AMPAC on the next day. After the ingredient’s analysis main orders will be placed shortly and JAS will continue to handle this business. Next opportunity will be export business out of AMPAC to overseas with the finished products.

JAS Korea is continuing to expand their reputation as the perfect solution for the transportation of pharmaceutical products in the market with these continued efforts excellent team-work. We are sure JAS will be leading the market in a near future.

Linkedin Logo

Asia Pacific

NEWS

Stay in the know with JAS
Asia Pacific
news.

Latest News

Celebrating sustainability success: JAS China recognized by the China-Italian Chamber of Commerce.

JAS China was honored with the 2025 Panda d'Oro-Sustainability Award at the annual China-Italian Chamber of Commerce awards ceremony. The sustainability award is presented to companies that actively promote green business practices and environmental responsibility. The recognition acknowledges JAS’s commitment to sustainable development and implementing strategies that have a real impact on business, society and environment. Cissy Lu, Chief Commercial Officer of JAS China, and Mario Tasso, Regional Account Manager JAS APAC, accepted the award on behalf of the company.
“This recognition belongs to every team member who has contributed to our sustainability journey. We will continue to drive green logistics innovation and corporate responsibility, contributing to a more sustainable future in China,” said Cissy Lu.

JAS's Commitment to Sustainability

A look at JAS China’s continuing efforts in environmental, social, and governance (ESG) excellence.

Key Achievements

  • Carbon Neutrality: Optimized logistics, adopted green packaging and biofuel insetting in cooperation with GoodShipping, and committed to Net Zero by 2050.
  • Circular Economy: Launched carbon offset solutions with Lune to promote sustainable packaging.
  • Certifications: Earned Ecovadis Bronze, CDP Rating C, SAQ B83, and Blue Whales Blue Skies Sapphire Ambassador status.
  • Diversity, Equity & Inclusion Recognized with HR Asia DE&I Award; promoted disability inclusion, and global workforce diversity in JAS China.
  • Employee Well-being: Offered Work From Home policy, flexible work arrangements, gym benefits, and ISO 45001 compliance.
#TogetherForSustainability

JAS is proud to be part of Lufthansa Cargo’s expanded network to Italy through its partnership with ITA Airways—and to be on board one of the inaugural flights from Brazil to Italy on June 16.

As part of our ongoing commitment to a more sustainable future, we booked the “Sustainable Choice” Add-on Service and purchased an additional 10,000 liters of Sustainable Aviation Fuel (SAF) to help reduce CO₂ emissions from the very start.

Together with Lufthansa Cargo, we're helping to shape the future of greener supply chains.

JAS recognized by Flowserve for excellence in global logistics.

JAS has once again been honored by Flowserve Corporation, a global leader in flow control solutions, securing the Freight Forwarder of the Year 2024 award. This marks the second year in a row JAS has been recognized by Flowserve, reinforcing its position as a trusted logistics partner in Flowserve’s supply chain.

JAS’s 2024 recognition builds on its exceptional 2023 performance, which included Customs Broker of the Year and Best Account Management of the Year awards, with a special commendation for Regional Account Manager Katarina Cook. Flowserve annually awards five logistics partners across three freight forwarding and two non-freight categories (e.g., trucking, small packages), making JAS’s multi-year success a testament to its operational excellence and client-centric approach.

“We are proud to receive this award; it is a testament to the dedication and passion of every JAS team member across the globe. It proves that at JAS, it’s our people who truly make the difference,” Manuele Mazzacurati, EVP Global Sales and Marketing, JAS.

“JAS plays a vital role in keeping our operations in motion. Their dedication to operational excellence, collaborative approach and innovative adoption of new technologies have been instrumental in supporting our mission to deliver reliable flow control solutions worldwide,” said Matt Dowgill, Flowserve’s Vice President of Global Supply Chain. “This award reflects not only their performance but also their commitment to helping Flowserve develop and mature our logistics function.”

About JAS

JAS, a global leader in logistics and supply chain solutions, was founded in Milan, Italy, in 1978. Headquartered in Atlanta, Georgia, and supported by 7,000+ team members in more than 100 countries, JAS focuses on creating solutions that are innovative, sustainable, and tailored to customer needs. As a privately owned company, JAS is committed to creating opportunities for communities, customers, and colleagues to thrive.

Our Sites use cookies for analytics purposes. For more information about the cookies we use on our Sites or how you can disable them, please see our Cookie Policy.